
Government approves IMPCL strategic sale to Skymap Pharmaceuticals for Rs 121 crore under competitive bidding as part of India’s disinvestment plan.
Primary dealers underwrite ₹21,000 crore through additional competitive underwriting on May 22, 2026
Financial support to developers will be provided at a maximum of 20% of the cost of plant and machinery through a competitive bidding process, where incentives will be disbursed in four equal instalments linked to project milestones. The incentive for a proje…